Evidence map›Paper›PMID 29219963›Full record

ArticleNature2017

Biotechnological mass production of DNA origami.

Florian Praetorius, Benjamin Kick, Karl L Behler, Maximilian N Honemann, Dirk Weuster-Botz, Hendrik Dietz

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. DNA Nanostructures for siRNA Delivery.Bioconjugate chemistry · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. DNA Origami and Its Applications in Synthetic Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  18. Review
  19. Article
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Florian PraetoriusTechnical University of Munich, Physics Department and Institute for Advanced Study, Am Coulombwall 4a, 85748 Garching bei München, Germany.
Benjamin KickTechnical University of Munich, Physics Department and Institute for Advanced Study, Am Coulombwall 4a, 85748 Garching bei München, Germany.
Karl L BehlerTechnical University of Munich, Institute of Biochemical Engineering, Boltzmannstrasse 15, 85748 Garching bei München, Germany.
Maximilian N HonemannTechnical University of Munich, Physics Department and Institute for Advanced Study, Am Coulombwall 4a, 85748 Garching bei München, Germany.
Dirk Weuster-BotzTechnical University of Munich, Institute of Biochemical Engineering, Boltzmannstrasse 15, 85748 Garching bei München, Germany.
Hendrik DietzTechnical University of Munich, Physics Department and Institute for Advanced Study, Am Coulombwall 4a, 85748 Garching bei München, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA nanotechnology, in particular DNA origami, enables the bottom-up self-assembly of micrometre-scale, three-dimensional structures with nanometre-precise features. These structures are customizable in that they can be site-specifically functionalized or constructed to exhibit machine-like or logic-gating behaviour. Their use has been limited to applications that require only small amounts of material (of the order of micrograms), owing to the limitations of current production methods. But many proposed applications, for example as therapeutic agents or in complex materials, could be realized if more material could be used. In DNA origami, a nanostructure is assembled from a very long single-stranded scaffold molecule held in place by many short single-stranded staple oligonucleotides. Only the bacteriophage-derived scaffold molecules are amenable to scalable and efficient mass production; the shorter staple strands are obtained through costly solid-phase synthesis or enzymatic processes. Here we show that single strands of DNA of virtually arbitrary length and with virtually arbitrary sequences can be produced in a scalable and cost-efficient manner by using bacteriophages to generate single-stranded precursor DNA that contains target strand sequences interleaved with self-excising 'cassettes', with each cassette comprising two Zn

Indexed as

BioreactorsNucleic Acid ConformationBase SequenceBiotechnologyDNA, CatalyticDNA, Single-StrandedNanotechnologyNanotubesDNA, CatalyticDNA, Single-Stranded

Identifiers

PMID29219963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.